Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine CR in elderly MDD outpatients
NCT00067444Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2003
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Jun 2003; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00067444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067444.